Vimpat is a medication prescribed to treat partial seizures. This selection from the eMedTV Web library takes an in-depth look at how the drug works and further explores its effects, potential side effects, general precautions, and dosage information.
Dizziness, nausea, and vomiting are among the most common side effects seen with Vimpat. This eMedTV Web segment highlights other possible side effects and explains which side effects may require immediate medical attention.
Vimpat is a medication that is used for treating partial seizures in people age 17 years old and older. This eMedTV Web resource discusses the uses of Vimpat in more detail, including information on how it works and possible off-label uses of the drug.
This eMedTV Web article explains that the typical starting dosage of Vimpat for treating partial seizures is 50 mg twice daily. This page further discusses the drug's dosages and also offers tips on when and how to use this medication.
When Vimpat is taken with certain other medicines, drug interactions may occur. This eMedTV resource offers more information on interactions with Vimpat, including which medicines may interfere with Vimpat and the negative effects of these interactions.
This eMedTV page lists important warnings and precautions with Vimpat, such as those relating to the drug's safety during pregnancy and the risk of suddenly stopping Vimpat. This page also discusses what you should tell your doctor prior to taking Vimpat.
You should seek immediate medical attention if you have overdosed on Vimpat (lacosamide). This eMedTV Web page covers what to do if you believe you have taken too much of this drug and describes various treatment options that are available.
Vimpat (lacosamide) may not be safe for use during pregnancy. This portion of the eMedTV library describes the results of animal studies on pregnancy and Vimpat, explaining how the medication increased the risk of fetal death and neurological problems.
Vimpat does pass through breast milk in rats. This eMedTV page explains the manufacturer's advice for breastfeeding women to avoid Vimpat and describes why your doctor may still recommend taking this seizure medicine if you are nursing a child.
Patents currently prevent any generic Vimpat (lacosamide) from being manufactured. This eMedTV page explains when a generic version may become available and describes the difference between a generic name and a generic version of a drug.
